Rekombinanter CD40L (Ruplizumab Biosimilar) Antikörper
-
- Target Alle CD40L (Ruplizumab Biosimilar) Produkte
- CD40L (Ruplizumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human, Hund
-
Wirt
-
Human
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD40L (Ruplizumab Biosimilar) Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Western Blotting (WB), Functional Studies (Func)
- Spezifität
- Recognizes and binds human CD40L with an IC50 of 0.845 μg/mL.
- Kreuzreaktivität
- Hund, Human
- Kreuzreaktivität (Details)
- Cross-reacts with canine CD40L.
- Reinheit
- >95 % (SDS-PAGE)
- Endotoxin-Niveau
- <0.001EU/μg
- Immunogen
- Recombinant human CD40L.
- Klon
- Hu5c8
- Isotyp
- IgG1
-
-
- Kommentare
-
This antibody is a biosimilar called Ruplizumab (Antova, BG9588) and originally developed by Biogen. Ruplizumab is a CD40 ligand blocker designed for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis, but withdrawn from clinical trials due to side effects.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- In PBS.
- Konservierungsmittel
- Without preservative
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 year after receipt when stored at -20°C. Stable for at least 3 months after receipt when stored at +4°C. - Haltbarkeit
- 12 months
-
- Target
- CD40L (Ruplizumab Biosimilar)
- Abstract
- CD40L (Ruplizumab Biosimilar) Produkte
- Synonyme
- CD154 antikoerper, CD40L antikoerper, HIGM1 antikoerper, IGM antikoerper, IMD3 antikoerper, T-BAM antikoerper, TNFSF5 antikoerper, TRAP antikoerper, gp39 antikoerper, hCD40L antikoerper, CD40 ligand antikoerper, CD40LG antikoerper
- Substanzklasse
- Biosimilar
- Hintergrund
- CD40 Ligand (CD40L), renamed TNFSF5 but now also known as CD154, TRAP and gp39, is a 34-39 kDa type II transmembrane glycoprotein, that belongs to the TNF superfamily, and a surface receptor expressed on activated T cells which acts as a costimulatory molecule to trigger immune responses. CD40L binds to CD40, which is essential in mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development and germinal center formation. CD40 is constitutively expressed by antigen presenting cells, including dendritic cells, B cells and macrophages. Consistent with its widespread expression on normal cells, CD40 is also expressed on a wide range of tumor cells. CD40L levels are increased in serum and in inflamed tissues of patients with autoimmune diseases.
- UniProt
- P29965
-